Liang-In Lin
Overview
Explore the profile of Liang-In Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
1487
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yen J, Keak P, Wu C, Chen H, Gao W, Liou J, et al.
Biomed Pharmacother
. 2024 Sep;
179:117395.
PMID: 39241566
Core binding factor acute myeloid leukemia (CBF-AML) stands out as the most common type of adult AML, characterized by specific chromosomal rearrangements involving CBF genes, particularly t(8;21). Shikonin (SHK), a...
2.
Tien F, Yao C, Cheng-Hong Tsai X, Lo M, Chen C, Lee W, et al.
Blood Cancer J
. 2024 Jan;
14(1):15.
PMID: 38253683
Acute myeloid leukemia (AML) with CEBPA bZIP in-frame mutations (CEBPA) is classified within the favorable-risk group by the 2022 European LeukemiaNet (ELN-2022). However, heterogeneous clinical outcomes are still observed in...
3.
Tseng C, Fu Y, Ou D, Lu J, Hou H, Lin L
Cancer Gene Ther
. 2023 Oct;
30(12):1691-1701.
PMID: 37821641
Omipalisib (GSK2126458), a potent dual PI3K/mTOR inhibitor, is reported to exhibit anti-tumor effect in several kinds of cancers. More than 50% of acute myeloid leukemia (AML) patients display a hyperactivation...
4.
Chen P, Lin C, Wu C, Keak P, Liou J, Gao W, et al.
Chem Biol Interact
. 2023 Sep;
385:110729.
PMID: 37777166
Acute myeloid leukemia (AML) is a disease characterized by abnormal cell proliferation in the bone marrow and is the most common quickly progressive leukemia in adults. Pinostrobin, a flavonoid phytochemical,...
5.
Lee W, Tsai M, Tsai C, Tien F, Lo M, Tseng M, et al.
Blood Cancer J
. 2023 Aug;
13(1):120.
PMID: 37558665
Myelodysplastic syndromes (MDS) have varied prognoses and require a risk-adapted treatment strategy for treatment optimization. Recently, a molecular prognostic model (Molecular International Prognostic Scoring System [IPSS-M]) that combines clinical parameters,...
6.
Lo M, Cheng-Hong Tsai X, Lin C, Tien F, Kuo Y, Lee W, et al.
Am J Hematol
. 2023 Mar;
98(5):760-769.
PMID: 36861732
The European LeukemiaNet (ELN) recently proposed a revised recommendation for the diagnosis and management of acute myeloid leukemia (AML) in adults, recognized as ELN-2022. However, validation in a large real-world...
7.
Yao C, Agathangelidis A, Chuang S, Tsou H, Feng W, Liu T, et al.
Hemasphere
. 2022 Dec;
6(12):e803.
PMID: 36452029
Asian patientswith chronic lymphocytic leukemia (CLL) exhibit immunoglobulin heavy variable (IGHV) gene repertoires that are distinct from those observed in Western populations, and a higher proportion of Asian CLL patients...
8.
Chen K, Hsu C, Su Y, Yuan C, Lin L, Tsai J, et al.
Br J Cancer
. 2022 Nov;
128(1):102-111.
PMID: 36319846
Background: Prognosis of metastatic BRAF V600E mutant colorectal cancer (CRC) is poor, and the prognostic implications of immune contextures in the tumour microenvironment (TME) for CRC remain elusive. Methods: We...
9.
Wu J, Wu H, Wu S, Tsai H, Weng S, Lin K, et al.
Mol Cancer Res
. 2022 May;
20(8):1222-1232.
PMID: 35533307
Implications: This phosphoproteomic analysis and functional validation illuminated the phosphorylation of KAP1 at S473 as an important downstream BCR signaling event and a potential indicator for the success of ibrutinib...
10.
Chang H, Su K, Goodman S, Cheng W, Lin L, Yang Y, et al.
J Vis Exp
. 2022 May;
(182).
PMID: 35532273
Uracil-DNA glycosylase (UDG) is a key component in the base excision repair pathway for the correction of uracil formed from hydrolytic deamination of cytosine. Thus, it is crucial for genome...